Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Edwards Lifesciences Corporation Banner

Edwards Lifesciences Corporation

EW Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
811.100M494.900M569.500M583.600M722.200M1.047B823.400M1.503B1.522B1.399B
Depreciation & Amortization
68.600M65.800M71.200M81.900M77.400M89.300M107.200M134.800M139.600M144.900M
Change in Working Capital
190.300M64.400M66.100M234.200M-42.600m-204.300m42.200M145.300M-421.400m-526.300m
Operating Cash Flow
1.022B549.700M704.400M1.001B926.800M1.179B1.054B1.732B1.218B895.800M
Capital Expenditure
-93.700m-106.500m-217.400m-175.500m-241.700m-278.400m-407.300m-329.800m-264.800m-266.300m
Free Cash Flow
928.600M443.200M487.000M825.200M685.100M901.000M647.000M1.402B953.400M629.500M
Debt Repayment
-239.000m-29.500m-31.400m-818.400m-1.125b-10.000m-17.000m-7.000m-200.000k-300.000k
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
113.300M87.200M103.300M113.800M147.000M160.500M140.500M158.600M146.400M169.900M
Common Stock Repurchased
-300.900m-280.100m-662.300m-763.300m-795.500m-263.300m-625.400m-512.800m-1.727b-879.600m
Net Change in Cash
233.400M64.600M211.700M-111.800m-104.200m465.000M15.800M-332.800m-94.800m375.400M